Skip to main content

Multidimensional Challenges in a suspicious case of Lung malignancy and patients uncertainty: What's the solution?

Disclaimer:-
This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here February 2017 after collecting informed patient consent (form downloadable Click Here)  by BMJ Elective Student. 

The journey of a patient which is raising multidimensional issues of both diagnostic challenge, therapeutic challenge & patients uncertainty:  
⇒ A 66 years-old-female presented to the emergency department with the complaints of left-sided chest pain for last 3 months which radiates to arm & shoulder and increases with cough. She also complaints of cough & pain in the abdomen & hoarseness of voice. 
⇒ She was admitted in the hospital with the same complaints 6 months back. Her past medical history is significant for hypertension (diagnosed 1 & 1/2 years back), osteoporosis D6, vocal cord palsy.
On examination: 
⇒ On admission, patient was investigated for 
       - Chest X-Ray (P/A & Lateral view), 
       - ECG, '
       - CBC, Urea, Creatinine & Na+, K+.  
Lab investigations results: 
Chest X-Ray (P/A View & Lateral view): 
 

ECG Report:






CECT scan of Thorax:






OLD Reports are: 


2 days after admission :
Mantoux Test & UG guided- diagnostic pleural fluid was aspirated where the reports are as follows:





Fluid for Malignancy:



# Lights criteria met based on the reports which were suggestive of the Exudative nature of the Pleural fluid. Mantoux test didn't show positive results and pleural fluid AFB stain also showed no growth for AFB.

Then Broncoscopy guided biopsy was scheduled BUT unfortunately biopsy sample couldn't be obtained and report is as follows:
⇒ On discussion with radiologist, they advised that FNAC can be done if  pleural fluid is tapped (USG Guided therapeutic + diagnostic pleural fluid tap) which would decrease the compression on the lung and thus CT guided FNAC/ biopsy from the lung mass can be obtained from the appropriate site.




⇒During the pleural tapping only 180 ml fluid was tapped while patient coughed and procedure was stopped and again tapping couldn't be done and also the CT guided FNAC.

⇒ Whole case was discussed with the patients son and on shared discussion patients son wanted to give a therapeutic trial of antituberculer treatment inspite of understanding that this is a case of suspicious malignancy and planned the discharge as follows:



In the whole scenario, it is seen that with repetitive attempt  for making the diagnosis confirmatory it couldn't be confirmed which raises the multidimensional issues of both diagnostic challenge, therapeutic challenge & patients uncertainty:  

1. What could be the other way for approaching to diagnosis in spite of trying different available modalities?
2. How the problem could be solved for doing FNAC in this case where sample was out of reach?

3. How could we overcome the therapeutic challenge that occurred because diagnosis couldn't be made?

4. How evidence based it is to give therapeutic trial of Anti-tuberculous drug (on patients demand) in an undiagnosed case of suspicious malignancy?

5. What is the effect of the whole challenges to patients uncertainty due to these challenges?





Comments

Popular posts from this blog

55 years Old male with Bipolar affected disorder moving from depression to Manic to depression phase

Disclaimer:- This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here December 2017 after collecting informed patient consent (form downloadable Click Here) This is a case of a 55 years old, diabetic, hypertensive patient who was diagnosed with Bipolar affected disorder since 1995. In 1995 due to financial loss he was attacked by this condition. He was seen by Dr. D. K Agarwala and diagnosed as BPAD-Depression phase and treated with lithium, sodium valporate, propranolol, Zeptol cr, Nitrosum - S.  With the treatment he was reasonably well but every 6 months of interval he appeared to have some disturbance like didn't want to talk to anybody, forgot to smile etc. They went to the doctor and treated accordingly and was continuing the treatment.  In the year of 2013, August he was diagnosed with BPAD-severe depression phase but, he was not responding well to the medications and then they went to NIMHANS for

Consent Forms

Hindi BMJ Consent form   Bengali BMJ Consent form English BMJ Consent form   Telegu BMJ Consent Form Telegu BMJ Consent Form   UDHC Consent Form                

drugs to avoid or use in terms of their pregnancy category

The optimal AEDs therapy of women with epilepsy who are of childbearing age is unclear because of a lack of conclusive data on the comparative teratogenicity of different antiseizure drugs and no antiepileptic drug has proven safe in pregnancy in terms of teratogenesis. Data on the comparative efficacy of various antiseizure drugs for controlling seizures during pregnancy are also quite limited, and there are no randomized trials in this setting. Treatment must be individualized for all patients. Women with epilepsy are classified as high risk during pregnancy and as there are no clear data indicating that any drug is without risk in pregnancy therefore, the antiseizure drug regimen should be optimized six months prior to planned conception.  Choice of antiepileptic drugs in women of childbearing age and  pregnant women with epilepsy:  1. T he antiseizure drug that stops seizures in a given patient is the one that should be used with an exception of valproate. 2.